high concentrations of igf-i were associated with an increased risk of prostate cancer (odds ratio comparing 75th with 25th percentile 1.49, 95% ci 1.14-1.95) and premenopausal breast cancer (1.65, 1.26-2.08) and high concentrations of igfbp-3 were associated with increased risk of premenopausal breast cancer (1.51, 1.01-2.27).